Aleksey S. Boev

Denis Bokhan, Alena S. Mastiukova, Aleksey S. Boev et al.

Multiclass classification is of great interest for various applications, for example, it is a common task in computer vision, where one needs to categorize an image into three or more classes. Here we propose a quantum machine learning approach based on quantum convolutional neural networks for solving the multiclass classification problem. The corresponding learning procedure is implemented via TensorFlowQuantum as a hybrid quantum-classical (variational) model, where quantum output results are fed to the softmax activation function with the subsequent minimization of the cross entropy loss via optimizing the parameters of the quantum circuit. Our conceptional improvements here include a new model for a quantum perceptron and an optimized structure of the quantum circuit. We use the proposed approach to solve a 4-class classification problem for the case of the MNIST dataset using eight qubits for data encoding and four ancilla qubits; previous results have been obtained for 3-class classification problems. Our results show that accuracies of our solution are similar to classical convolutional neural networks with comparable numbers of trainable parameters. We expect that our finding provide a new step towards the use of quantum neural networks for solving relevant problems in the NISQ era and beyond.

A. I. Gircha, A. S. Boev, K. Avchaciov et al.

Deep generative chemistry models emerge as powerful tools to expedite drug discovery. However, the immense size and complexity of the structural space of all possible drug-like molecules pose significant obstacles, which could be overcome with hybrid architectures combining quantum computers with deep classical networks. As the first step toward this goal, we built a compact discrete variational autoencoder (DVAE) with a Restricted Boltzmann Machine (RBM) of reduced size in its latent layer. The size of the proposed model was small enough to fit on a state-of-the-art D-Wave quantum annealer and allowed training on a subset of the ChEMBL dataset of biologically active compounds. Finally, we generated 2331 novel chemical structures with medicinal chemistry and synthetic accessibility properties in the ranges typical for molecules from ChEMBL. The presented results demonstrate the feasibility of using already existing or soon-to-be-available quantum computing devices as testbeds for future drug discovery applications.